AAN 2026 18 - 22 April 2026

Semaglutide Concentration in Cerebrospinal Fluid from Patients with Early Alzheimer’s Disease After 12 Weeks of Subcutaneous Treatment

Authors :

Susan Alford¹; Peter Johannsen²; Marie Bentsen²; Dylan Belmont Rausch²; Lisbeth Carstensen²; Rose Jeppesen²; Gabriel Martino²; Martí Jiménez-Mausbach²; Lotte Knudsen²

Affiliations

View Details Hide Details

Download .PDF

Keywords

Neurology

Congress poster

GLP-1 RA

Semaglutide

PHASE 3 (RCT)

Search Science Hub

Are you a healthcare professional?

Semaglutide Concentration in Cerebrospinal Fluid from Patients with Early Alzheimer’s Disease After 12 Weeks of Subcutaneous Treatment